New Drug, New Guidelines and More…

Posted on by

Some of the stories that caught my attention:

  • Vietnam veterans exposed to Agent Orange have an increased risk of developing multiple myeloma, a new study suggests.
  • The FDA approved Varubi (rolapitant), a drug to prevent chemotherapy induced nausea and vomiting. The drug was approved after three phase 3 clinical trials involving 2800 adults.
  • A recent study published in JAMA Surgery shows a rise in double mastectomy among males. While male breast cancer cases are less common than women, men are less likely to survive the disease. Results analyzed in this paper, revealed that during a seven year period, double mastectomies for men went from 3% in 2004 to 5.6% in 2011.
  • The American Society of Clinical Oncology (ASCO) released new guidelines on genetic and genomic testing. The guidelines were published online in the Journal of Clinical Oncology and are available on the ASCO website.

News on and About Social Media

Posted on by

Reports on mobile etiquette and mobile messaging and Health News Review’s recent picks of great writing on healthcare in this edition of Blog Buzz…

  • For those interested in social media, mobile technologies and changing social norms, the Pew Research Center released two reports last month that are worth checking out. On August 19th, a report on Mobile Messaging and Social Media – which looks at various social media platforms, the growth of specific platforms, along with the demographics of users and their frequency of use – was released. On the 26th came Americans’ Views on Mobile Etiquette.
  • Health News Review has a feature called Five Star Friday which highlights great news stories covering healthcare and related issues. Among other things, this week’s linked to Science Isn’t Broken by Christine Aschwanden, an older post that has gotten a good deal of attention and is worth a look. Other items in this roundup cover a building boom in cancer centers and a discussion on precision medicine.